Dr. Thomas Dudley Kimble, MD

Dr. Kimble practices at Evms Medical Group in Norfolk, Virginia.

Dr. Kimble's NPI, 1649359993, was assigned on November 6, 2006. Dr. Kimble graduated from Howard University College of Medicine in 2002. Dr. Kimble holds Virginia license 0101240761.

Dr. Kimble's primary practice is Evms Medical Group, at 825 Fairfax Ave Ste 563 Suite 563, Norfolk, VA 23507. The practice phone is (757) 446-8990.

Dr. Kimble's primary practice is Evms Medical Group in Norfolk, Virginia. The medical group on file is EVMS Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kimble practices. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Kimble's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Kimble is licensed in Virginia.

CMS data shows 12 Medicare services from Dr. Kimble across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $768 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Kimble in 2024. The largest group is under 65, with 14 patients. 54% of them have high blood pressure, and 54% have high cholesterol. 42% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kimble's median patient age at 38, with 100% women.

In 2024, Dr. Kimble wrote 80 Medicare Part D claims for 40 patients. 90% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $345 in total drug cost. In 2023, CMS named 70 claims across 4 drugs.

Dr. Kimble accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Kimble, published from 2012 to 2023. 2017 was the busiest year, with 4. The most frequent topics are Vagina, Administration, Intravaginal and Estradiol. Dr. Kimble has published most often in Contraception. Dr. Kimble's most frequent co-authors are Jill Schwartz, David Fitzgerald Archer, MD and Betsy C. Herold, MD.

Dmand AI links Dr. Kimble to 1 clinical trial. Conditions studied include Squamous Intraepithelial Lesions and Morphological and Microscopic Findings.

CMS Open Payments shows 374 general payments to Dr. Kimble from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Abbvie Inc. paid the most, $166,659.

Dr. Kimble graduated from Howard University College of Medicine in 2002.